Lineage Cell Therapeutics (LCTX) Reports In-Line Q3 EPS

Go back to Lineage Cell Therapeutics (LCTX) Reports In-Line Q3 EPS
(NYSE: LCTX) Delayed: 1.29 +0.03 (2.38%)
Previous Close $1.26    52 Week High
Open $1.24    52 Week Low
Day High $1.29    P/E N/A 
Day Low $1.24    EPS
Volume 259,590